- CRISPR Technology Where it Stands and What the Future HoldsPosted 3 days ago
- Ask the Expert – Using Luminex Technology to Non-Invasively Monitor Stem Cell DifferentiationPosted 6 days ago
- Controlling Cell Culture pH in BioreactorsPosted 2 weeks ago
- The Impact of Aeration on Cell Culture OptimizationPosted 4 weeks ago
- Cool Tool – Novel universal titer boost and enhancer improves CHO cell protein production in small bioreactorsPosted 1 month ago
- The Dish’s Weekly Biotechnology News Wrap Up – September 16, 2016Posted 1 month ago
- Utilizing UVC LEDs in Biotech and Pharma – Paving the way to better instrument design and better manufacturing methodsPosted 1 month ago
- Synopsis: An Interview with Audrey Jia, former FDA CMC Reviewer for Biological ProductsPosted 1 month ago
- Predicting Differentiation and Characterizing Pluripotent Stem Cells Using Non-invasive Multi-analyte Luminex® AssaysPosted 1 month ago
- Particulates in Cell Therapy Products – An important issue for commercializationPosted 1 month ago
Cool Tool – ATMI’s Helium Integrity Testing (HIT) system
ATMI’s helium integrity testing (HIT™) system has been causing a real buzz at this year’s INTERPHEX trade show, the HIT platform fits directly into ATMI’s continued stance as advocates for the single-use industry. First launched in 2010 as an in-house add-on testing service for the company’s 2-D bioprocess vessels and manifolds, the HIT system has evolved to the next level. It is now being offered in multiple formats: either as add-on testing for the full line of ATMI 2-D and 3-D vessels, or as a point-of-use-system to customers for implementation in their own facilities.
The HIT platform is now commercially available for testing bags and manifolds from 1L through to 200L,” said Mario Philips, senior vice president and general manager of ATMI Life Sciences. “We have had positive feedback from customers so far, and are hearing that they want this technology fully scaled. As such, we have projects in the works to ultimately scale the HIT system to support testing of up to 1,000L.”
The HIT platform adds an extra level of security to process operations. The bags and manifolds can be tested right at the customer site—before use. For processes where the product value can easily run into hundreds of thousands of dollars, this is really important.
“The HIT system gives much more sensitivity than standard pressure decay testing,” commented Vishwas Pethe, Research Engineer at ATMI LifeSciences. “As one of the original engineers working on this project, it has been very fulfilling to advance it based on customer input. The HIT technology is unmatched in the market—not only do we provide customers with the chance to test both the bags and the manifolds, but we also give them the ability to test for defects as small as 10µm. This level of detection is critical to ensuring the sterility of a bag.”
The full press release on ATMI’s HIT platform can be found by clicking here.
Please join us on Cell Culture Dish next month, when we feature ATMI LifeSciences in an “Ask the Experts” segment to further discuss HIT and the ATMI portfolio of products.